This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
Latency changes how an outbreak begins
The Merck herpesvirus reference explains that EHV-1 can remain latent after infection and later reactivate. Virus spreads through respiratory secretions, and reproductive tissues or fluids from an abortion can also be infectious. Infection is therefore broader than a visible coughing episode at an event.
This biology complicates attempts to assign blame to the newest arrival. Keep a factual contact history, but let the investigation determine what that history supports. A horse that looked well during transport may still be relevant; an earlier resident may also have a meaningful role. Appearance alone does not reconstruct the source.
One virus can produce different clinical problems
APHIS guidance describes respiratory signs and reproductive loss, with some infections producing EHM. Neurologic findings can include hindlimb weakness, stumbling, reduced tail tone, urinary difficulty or inability to rise. Some infected horses have few obvious signs, so a stable's case definition needs veterinary direction.
Report these observations as separate findings rather than insisting every affected horse match one pattern. A mare's abortion and another horse's fever may belong in the same investigation even if neither animal is coughing. Do not move an unsteady horse repeatedly to demonstrate its gait or treat urinary dribbling as a simple behavior issue.
EHV-1 and EHV-4 are related, distinct identities
Both viruses are important causes of equine respiratory disease, but their names should not be merged in a laboratory record. Merck associates EHV-1 particularly with abortion and EHM. Preserve the assay's actual identification and interpretation; an entry reading only “herpes positive” may be too vague to support the decision being considered.
The equine influenza reference provides another explanation for fever and cough. Other neurologic diseases, including West Nile virus and rabies, need consideration according to the examination and exposure history. A compatible sign is a starting point for differential diagnosis.
Testing answers a defined clinical question
Merck describes PCR testing of respiratory samples or blood as central to diagnosis. The veterinarian chooses tests according to the presentation and stage of disease. Evidence of virus and the clinical diagnosis of EHM are related questions, but a positive result should not be expanded into a claim that every horse will develop neurologic illness.
Ask which horse was tested, why that animal was selected and how the result changes management. An initial result may need to be considered alongside repeated clinical observations or further investigation. A negative test should not independently cancel a stable restriction established from a wider outbreak assessment.
Supportive care must match the affected system
APHIS describes supportive treatment, with more intensive care sometimes needed for severe neurologic disease. Breathing, hydration, comfort, mobility and the ability to urinate may each influence the plan. Decisions about antivirals or other medicines belong with the treating veterinarian; an owner should not choose an internet regimen from the label EHM alone.
Agree on practical escalation points and on how a horse requiring hospital care can be received safely. Contact the receiving facility before travel. This protects the patient while allowing the hospital to plan isolation and staffing rather than discovering a possible infectious neurologic case at the unloading area.
Vaccination and contact control serve different purposes
APHIS states that available vaccines can reduce respiratory disease and abortion risk, but they do not provide effective protection against EHM. Keep the actual vaccine and dates available. “Vaccinated for herpes” should not be taken as assurance against neurologic disease or as a reason to ignore compatible signs.
Separate new or returning horses under a veterinary plan, avoid shared equipment and control movement during a suspected event. Include pregnant mares in the discussion. The biosecurity collection helps organize these tasks; the EHV investigation determines when a particular group can safely return to ordinary activity.
Questions about EHV-1
Is EHM a different virus?
EHM names the neurologic syndrome associated with equine herpesvirus infection. It should not replace the specific laboratory identification.
Can people catch equine herpesvirus from horses?
APHIS states that the equine herpesviruses discussed in its guidance do not pose a risk to people. People can still transfer contaminated material between horses.
Does a recovered horse provide proof of a virus-free stable?
No. Recovery of one patient and release of a group from outbreak controls are different decisions requiring the veterinarian's assessment.
Cite this reference
LivestockDefense. “Equine herpesvirus 1: respiratory disease, abortion and EHM.” Updated 2026-10-29. https://livestockdefense.com/threats/equine-herpesvirus-1/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- Merck Veterinary Manual: Equine Herpesvirus Infection
Source update: 2026-09. Most recent check: 2026-10-29.
Latency/reactivation, EHV-1 respiratory/reproductive/neurologic outcomes and purpose-specific PCR diagnosis; no sampling technique.
- USDA Animal and Plant Health Inspection Service: Equine Herpesvirus
Source update: 2025-07-30. Most recent check: 2026-10-29.
Equine signs, contact and contaminated-material spread, supportive care and limitations of vaccines against EHM.
